Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Evotec AG    EVT   DE0005664809

EVOTEC AG (EVT)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Evotec AG: Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/29/2017 | 12:15pm CET

DGAP Total Voting Rights Announcement: Evotec AG / Total Voting Rights Announcement
Evotec AG: Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

29.09.2017 / 12:13
Total Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Publication of total number of voting rights

1. Details of issuer
Evotec AG
Manfred Eigen Campus / Essener Bogen 7
22419 Hamburg
Germany

2. Type of capital measure
  Type of capital measure Date of status / date of effect
X Conditional capital increase (Sec. 26a para. 2 WpHG) 29.09.2017
  Other capital measure (Sec. 26a para. 1 WpHG)

3. New total number of voting rights:
147494037



29.09.2017 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Evotec AG
Manfred Eigen Campus / Essener Bogen 7
22419 Hamburg
Germany
Internet: www.evotec.com

 
End of News DGAP News Service

614487  29.09.2017 

fncls.ssp?fn=show_t_gif&application_id=614487&application_name=news&site_id=zonebourse

© EQS 2017
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on EVOTEC AG
12/15 EVOTEC : enters into research collaboration with CRTD to discover novel therapie..
12/13 EVOTEC : Academic Bridge LAB282 with Oxford University celebrating one year of i..
12/13 EVOTEC AG : Release according to Article 26, Section 1 of the WpHG [the German S..
12/13 EVOTEC : Enters into Research Collaboration with CRTD to Discover Novel Therapie..
12/13 EVOTEC : enters into research collaboration with CRTD to discover novel therapie..
12/12 CORRECTION OF A RELEASE FROM 11.12.2 : 40 CET/CEST - Evotec AG: Release accordin..
12/11 EVOTEC : Academic Bridge LAB282 with Oxford University Celebrating One Year of I..
12/11 EVOTEC AG : Release according to Article 26, Section 1 of the WpHG [the German S..
12/11 EVOTEC : S academic bridge lab282 with oxford university celebrating one year of..
12/04 EVOTEC : receives clinical milestone as part of its discovery alliance with Boeh..
More news
News from SeekingAlpha
12/13 Evotec enters into research collaboration with CRTD to discover therapies for..
11/17 Evotec (EVTCY) Presents At Jefferies 2017 London Healthcare Conference - Slid..
11/11 Evotec's (EVOTF) CEO Werner Lanthaler on Q3 2017 Results - Earnings Call Tran..
11/08 MY JOURNEY TO FINANCIAL INDEPENDENCE : 85-Stock October Portfolio Update - Buyin..
11/08 Evotec AG ADR 2017 Q3 - Results - Earnings Call Slides
Financials (€)
Sales 2017 246 M
EBIT 2017 45,7 M
Net income 2017 28,2 M
Debt 2017 103 M
Yield 2017 -
P/E ratio 2017 66,17
P/E ratio 2018 45,42
EV / Sales 2017 8,47x
EV / Sales 2018 6,31x
Capitalization 1 977 M
Chart EVOTEC AG
Duration : Period :
Evotec AG Technical Analysis Chart | EVT | DE0005664809 | 4-Traders
Technical analysis trends EVOTEC AG
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 6
Average target price 17,5 €
Spread / Average Target 31%
EPS Revisions
Managers
NameTitle
Werner Lanthaler Chief Executive Officer
Wolfgang Plischke Chairman-Supervisory Board
Mario Polywka Chief Operating Officer
Enno Spillner Chief Financial Officer
Cord E. Dohrmann Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
EVOTEC AG89.40%2 323
CELLTRION, INC.--.--%23 756
IQVIA HOLDINGS INC34.41%21 227
INCYTE CORPORATION-2.16%20 346
LONZA GROUP62.09%19 523
ALNYLAM PHARMACEUTICALS, INC.233.49%12 349